Skip to main content

Table 2 Top ten features (m/z ratio) selected by Wilcoxon rank test method in our 10 fold cross validation.

From: Classification of premalignant pancreatic cancer mass-spectrometry data using decision tree ensembles

Rank

Round 1

Round 2

Round 3

Round 4

Round 5

Round 6

Round 7

Round 8

Round 9

Round 10

Most Frequent

1

5798.9

5798.9

4941.6

5801.2

5822.1

5819.8

5801.2

5798.9

4941.6

5801.2

5798.9

2

5801.2

5801.2

5819.8

5798.9

5819.8

5822.1

5798.9

5801.2

11774

5798.9

5801.2

3

4941.6

11472

5822.1

4941.6

5798.9

5798.9

4941.6

11472

5798.9

5796.5

11472

4

5796.5

5819.8

5801.2

5819.8

5801.2

5801.2

5803.5

11477

11770

11472

5819.8

5

5819.8

11477

5798.9

9706.1

11472

11592

5822.1

11774

11477

5803.5

5822.1

6

5822.1

5822.1

4943.6

5822.1

11477

11587

11472

11770

11472

11592

11477

7

4943.6

11468

11592

5803.5

11468

11472

5819.8

11541

5819.8

11541

11541

8

11472

5796.5

11541

5796.5

11770

11541

11477

11537

5822.1

5819.8

4941.6

9

11774

11541

11472

11472

4941.6

11774

5829.1

11468

5801.2

11477

11774

10

11477

11481

11597

9710

11774

5796.5

11541

11481

11481

11468

5796.5

  1. Rank is determined by the probability of the two means between disease and control groups in the training set being significantly different.